Made
possible by charitable contributions from
Amgen
Oncology , AstraZeneca , Ferring Pharmaceuticals and GTx
Our monthly newsletter, the HotSheet, highlights the latest in treatment strategies as well as emerging treatments. The HotSheet is distributed
free at chapter support group meetings, and is available in PDF on the Us TOO web site.
HotSheet Personal Subscriptions Now Available
If you are unable to attend chapter meetings to get the latest issue or prefer an original copy, we can deliver the newsletter right to your home or office.
Download and print a subscription order form
or order online .
January - March |
April - June | July - September | October - Decembar
January View Newsletter
February View Newsletter
March View Newsletter
Includes:
Degarelix vs. Leuprolide in Advanced Prostate Cancer: Further Analysis of a Phase III Pivotal Trial
Us TOO Names New Board Reps for 2010
Dendreon Receives FDA Acknowledgement of Complete Response for Provenge BLA Resubmission
Doc Moyad’s “No Bogus Science” Column—Statins & Low Cholesterol “Hit Another Home Run”
Drug Eases ADT Side Effect in Men
PSA Screening Should Be Offered to Older Men
Read
more..
Includes:
ERSPC Study Shows PSA Screening Reduced Prostate Cancer Deaths by 20 Percent
PSA Velocity May Help Identify Insignificant Prostate Cancer
NCCN Prostate Cancer Guidelines Stress Careful Consideration of Active Surveillance
An Update of the Gleason Grading System
Coffee May Cut Risk of Prostate Cancer
Radiofrequency Ablation Safe and Effective for Reducing Pain from Bone Metastases
Ask Dr. Snuffy Myers
Read more..
Includes:
Public-Private Divide in Prostate Cancer Treatment
Exercise May Prevent Incontinence from Prostate Cancer Surgery
Similar Effectiveness among Management Options for Low-Risk Prostate Cancer
Soy May Protect Against Prostate Cancer
ZERO’s ―Prostate Polar Plunge
Ask Dr. Snuffy Myers
Alternative Prostate Cancer Vaccine Shows Promise
Frequent Sex and Masturbation in 20s and 30s Linked to Higher Prostate Cancer Risk
Read more..
April View Newsletter
MAY View Newsletter
June View Newsletter
Includes:
New Prostate Cancer Screening Guidelines – Commentary by Dr. Len Lichtenfeld
AUA Responds to Updated ACS Guidelines
Complex New Guidelines from Multiple Organizations Confuse Men about Prostate Cancer Screening
American Cancer Society – Ignorance is Bliss When it Comes to Prostate Cancer
Which Men Should Take Finasteride?
Robot-Assisted Surgery Is no Better Treatment for Prostate Cancer
American Cancer Society Updates Guidelines
Doc Moyad’s “No Bogus Science” Column – Weight Loss Supplements Are a Problem So Be Careful
Read more..
Includes:
ASCO Statement on the Passage of the Patient Protection & Affordable Health Care Act
A Treatment for Prostate Cancer “Inadequate” Half the Time
Positive Results for Sanofi-Aventis Drug
PSA & the PSA Test: What the Public Needs to Know
Infertility & Prostate Cancer May Have a Common Cause
Ask Dr. Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – L-Theanine Anti-Stress Amino Acid Found in Tea
Doctor Chodak’s Bottom Line
Read more..
Includes:
FDA Approves Prostate Cancer Vaccine
Active Surveillance May Not Be Best Option
MDV3100 Shows “Substantial Activity” in Advanced Prostate Cancer
Radiation for Prostate Cancer Lacks Data
Discussing Provenge with Cancer Patients®
Prostate Cancer Progresses More Quickly in African-American Men
Ask Dr. Snuffy Myers
Doc Moyad’s “No Bogus Science” Column – Provenge® Receives FDA Approval
FDA Scrutiny of GnRH Agonists Continues
Degarelix Shows Promise as Second-Line Hormonal Therapy for Prostate Cancer
Patients
Read more..
July View Newsletter
August View Newsletter
September View Newsletter
Includes:
RT Shown Beneficial for Prostate Cancer Subset
Denosumab Extends Time to Bone Events
Us TOO Seeks Board Member Applications
High-Intensity Focused Ultrasound (HIFU) Non-Inferior to EBRT for Prostate
Cancer
Cabazitaxel Benefit Confirmed in Prostate Cancer Now FDA Approved (Jevtana® ,
sanofi-aventis)
Doc Moyad’s “No Bogus Science” Column – “Exercise Ups Cialis® , Levitra® &
Viagra® ”
Pelvic RT Increases Hip Fracture Risk in Men
Bevacizumab (Avastin® ) Fails to Prolong Survival in Resistant Prostate Cancer
PSA Misses the Mark in Active Surveillance
Read more..
Includes:
Medicare to Review Provenge® Coverage
Patients Face Yearlong Rationing of Provenge
Leather Wristbands Help Raise Awareness, Prostate Cancer Funds
PSA Test Does Cut Prostate Cancer Deaths
Cabazitaxel (Jevtana®) New Chemotherapy Approved for Advanced Prostate Cancer
Doc Moyad’s “No Bogus Science” Column – “Too Much Vitamin D3 Is Not a Good Thing”
Ask Doctor Snuffy Myers
Seeking Patients for New Study to Improve Prediction of Prostate Biopsy Results
Statins Reduce PSA Spikes After Surgery
Read more..
Includes:
Immunotherapy Benefits Prostate Cancer
Bone Density May Predict Prostate Cancer
Dendreon’s $93K Price Must Be Paid by US
PSA Screening Can Lead to Overtreatment
PAF Announces Additional Support for Co-Pay Relief Program for Prostate Cancer
Doc Moyad’s “No Bogus Science” Column – “Too Much Folic Acid May Not Be Good”
Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy
Ask Doctor Snuffy Myers
Stand Up to Cancer Is Back
Five New Genetic Variations Linked to Prostate Cancer in Study on Japanese Men
Read more..
HotSheets by Year
